Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Merck
Start Date
April 29, 2017
End Date
March 9, 2025
Administered By
Duke Cancer Institute
Awarded By
Merck
Start Date
April 29, 2017
End Date
March 9, 2025